Forbion

Forbion is a Naarden-based European life sciences venture capital firm focused exclusively on biotechnology and pharmaceutical innovation. The firm manages several dedicated funds with over €1.5 billion under management, backing Seed through Series B companies developing transformative medicines for patients with serious diseases. Forbion typically deploys $5M–$25M per investment and has a deep network of scientific advisors, healthcare executives, and co-investors that it deploys to help portfolio companies advance their drug development programmes. Portfolio companies include Acacia, Galecto, Novintum, and uniQure.